February 2012 – content
Life Sciences
Ocimum auction “successful”
BioTek Instruments opens Shanghai and French office
Quanterix gets strategic investment
Febit renames to CBC
IntegenX raises $40 million
Roche makes hostile take over bid for Illumina
Sony DADC and Axela to develop immunoassay consumables
Takara licenses thermal cycler patents from Eppendorf
OpGen launches Genome-Builder software
General Laboratory
FEI buys Aspex Corp
Scitek Australia appointed Pfeiffer’s exclusive distributor
Agilent Technologies Expands Vacuum Products Portfolio
Labsphere appoints Canadian representative
Edwards to create technology centre in UK
Preproduction mini MS reaches selected customers
Accelrys buys further ELN developer
Process & hand-held instrumentation
LumaSense acquires Reliability Point
DASGIP acquisition adds to Eppendorf’s cell culture portfolio
Gasmet Technologies restructures
Features – End-user markets
Confidence wavers as economic malaise affects research spending
Finanicals
Weak research spending troubles life science firms
Acquisitions keep Techne on track
Cepheid stock lifts despite loss
Olympus down on exchange rate
Gen-Probe slips into the red
Merck Millipore maintains growth
Lab firms pick their way through chillier winds
NVE slips in a challenging quarter
JEOL lowers full-year forecasts
Biohit back in the black
Flat quarter for Corning Life Sciences
Waters beats targets in Q4
Firms see signs of strengthening chip sector
Diploma surges on strong hospital spending
Renishaw invests in growth
Teradyne ahead of targets
Instrument sales weaken at Intevac
Strong US demand drivers Parker
Appointments